转移性葡萄膜黑色素瘤 - Suppr

Suppr

超能文献

Metastatic uveal melanoma.

作者信息

Kivelä Tero, Eskelin Sebastian, Kujala Emma

机构信息

Department of Ophthalmology, Helsinki University Central Hospital, Finland.

出版信息

Int Ophthalmol Clin. 2006 Winter;46(1):133-49. doi: 10.1097/01.iio.0000195861.71558.13.

DOI:10.1097/01.iio.0000195861.71558.13

PMID:16365560

Abstract

摘要

相似文献

Metastatic uveal melanoma.

Int Ophthalmol Clin. 2006 Winter;46(1):133-49. doi: 10.1097/01.iio.0000195861.71558.13.

Disseminated tumour cells in bone marrow of patients with uveal melanoma.

Acta Ophthalmol. 2013 Jun;91(4):343-8. doi: 10.1111/j.1755-3768.2012.02449.x. Epub 2012 May 25.

Disparities in Uveal Melanoma: Patient Characteristics.

Semin Ophthalmol. 2016;31(4):296-303. doi: 10.3109/08820538.2016.1154176. Epub 2016 Apr 29.

Metastatic uveal melanoma.

Ophthalmol Clin North Am. 2005 Mar;18(1):143-50, ix. doi: 10.1016/j.ohc.2004.07.003.

[Prognostic factors for uveal melanoma].

Vestn Oftalmol. 2015 Jan-Feb;131(1):90-95. doi: 10.17116/oftalma2015131190-94.

Uveal melanoma: natural history and treatment options for metastatic disease.

Melanoma Res. 1999 Dec;9(6):575-81.

Anti-PD1 treatment in metastatic uveal melanoma in the Netherlands.

Acta Oncol. 2017 Jan;56(1):101-103. doi: 10.1080/0284186X.2016.1260773. Epub 2016 Dec 2.

Use of fluorescence in situ hybridization to distinguish metastatic uveal from cutaneous melanoma.

Int J Surg Pathol. 2012 Jun;20(3):246-51. doi: 10.1177/1066896912438589. Epub 2012 Mar 13.

Variates of survival in metastatic uveal melanoma.

J Clin Oncol. 2005 Nov 1;23(31):8076-80. doi: 10.1200/JCO.2005.02.6534.

Uveal melanoma: epidemiologic aspects.

Ophthalmol Clin North Am. 2005 Mar;18(1):75-84, viii. doi: 10.1016/j.ohc.2004.07.002.

引用本文的文献

Treatment of Metastatic Uveal Melanoma: Systematic Review.

Cancers (Basel). 2020 Sep 8;12(9):2557. doi: 10.3390/cancers12092557.

Blood Biomarkers of Uveal Melanoma: Current Perspectives.

Clin Ophthalmol. 2020 Jan 20;14:157-169. doi: 10.2147/OPTH.S199064. eCollection 2020.

miR-652 Promotes Proliferation and Migration of Uveal Melanoma Cells by Targeting HOXA9.

Med Sci Monit. 2019 Nov 19;25:8722-8732. doi: 10.12659/MSM.917099.

Overall survival after treatment for metastatic uveal melanoma: a systematic review and meta-analysis.

Melanoma Res. 2019 Dec;29(6):561-568. doi: 10.1097/CMR.0000000000000575.

Targeting MDMX and PKCδ to improve current uveal melanoma therapeutic strategies.

Oncogenesis. 2018 Mar 29;7(3):33. doi: 10.1038/s41389-018-0041-y.

Combined inhibition of CDK and HDAC as a promising therapeutic strategy for both cutaneous and uveal metastatic melanoma.

Oncotarget. 2017 Dec 15;9(5):6174-6187. doi: 10.18632/oncotarget.23485. eCollection 2018 Jan 19.

p63 is required beside p53 for PERP-mediated apoptosis in uveal melanoma.

Br J Cancer. 2016 Oct 11;115(8):983-992. doi: 10.1038/bjc.2016.269. Epub 2016 Sep 1.

Chemosaturation with percutaneous hepatic perfusion for unresectable metastatic melanoma or sarcoma to the liver: a single institution experience.

J Surg Oncol. 2014 Apr;109(5):434-9. doi: 10.1002/jso.23501. Epub 2013 Nov 19.

High levels of Hdmx promote cell growth in a subset of uveal melanomas.

Am J Cancer Res. 2012;2(5):492-507. Epub 2012 Aug 20.

Quality of evidence about effectiveness of treatments for metastatic uveal melanoma.

Trans Am Ophthalmol Soc. 2008;106:128-35; discussion 135-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Metastatic uveal melanoma.

Int Ophthalmol Clin. 2006 Winter;46(1):133-49. doi: 10.1097/01.iio.0000195861.71558.13.

Disseminated tumour cells in bone marrow of patients with uveal melanoma.

Acta Ophthalmol. 2013 Jun;91(4):343-8. doi: 10.1111/j.1755-3768.2012.02449.x. Epub 2012 May 25.

Disparities in Uveal Melanoma: Patient Characteristics.

Semin Ophthalmol. 2016;31(4):296-303. doi: 10.3109/08820538.2016.1154176. Epub 2016 Apr 29.

Metastatic uveal melanoma.

Ophthalmol Clin North Am. 2005 Mar;18(1):143-50, ix. doi: 10.1016/j.ohc.2004.07.003.

[Prognostic factors for uveal melanoma].

Vestn Oftalmol. 2015 Jan-Feb;131(1):90-95. doi: 10.17116/oftalma2015131190-94.

Uveal melanoma: natural history and treatment options for metastatic disease.

Melanoma Res. 1999 Dec;9(6):575-81.

Anti-PD1 treatment in metastatic uveal melanoma in the Netherlands.

Acta Oncol. 2017 Jan;56(1):101-103. doi: 10.1080/0284186X.2016.1260773. Epub 2016 Dec 2.

Use of fluorescence in situ hybridization to distinguish metastatic uveal from cutaneous melanoma.

Int J Surg Pathol. 2012 Jun;20(3):246-51. doi: 10.1177/1066896912438589. Epub 2012 Mar 13.

Variates of survival in metastatic uveal melanoma.

J Clin Oncol. 2005 Nov 1;23(31):8076-80. doi: 10.1200/JCO.2005.02.6534.

Uveal melanoma: epidemiologic aspects.

Ophthalmol Clin North Am. 2005 Mar;18(1):75-84, viii. doi: 10.1016/j.ohc.2004.07.002.

引用本文的文献

Treatment of Metastatic Uveal Melanoma: Systematic Review.

Cancers (Basel). 2020 Sep 8;12(9):2557. doi: 10.3390/cancers12092557.

Blood Biomarkers of Uveal Melanoma: Current Perspectives.

Clin Ophthalmol. 2020 Jan 20;14:157-169. doi: 10.2147/OPTH.S199064. eCollection 2020.

miR-652 Promotes Proliferation and Migration of Uveal Melanoma Cells by Targeting HOXA9.

Med Sci Monit. 2019 Nov 19;25:8722-8732. doi: 10.12659/MSM.917099.

Overall survival after treatment for metastatic uveal melanoma: a systematic review and meta-analysis.

Melanoma Res. 2019 Dec;29(6):561-568. doi: 10.1097/CMR.0000000000000575.

Targeting MDMX and PKCδ to improve current uveal melanoma therapeutic strategies.

Oncogenesis. 2018 Mar 29;7(3):33. doi: 10.1038/s41389-018-0041-y.

Combined inhibition of CDK and HDAC as a promising therapeutic strategy for both cutaneous and uveal metastatic melanoma.

Oncotarget. 2017 Dec 15;9(5):6174-6187. doi: 10.18632/oncotarget.23485. eCollection 2018 Jan 19.

p63 is required beside p53 for PERP-mediated apoptosis in uveal melanoma.

Br J Cancer. 2016 Oct 11;115(8):983-992. doi: 10.1038/bjc.2016.269. Epub 2016 Sep 1.

Chemosaturation with percutaneous hepatic perfusion for unresectable metastatic melanoma or sarcoma to the liver: a single institution experience.

J Surg Oncol. 2014 Apr;109(5):434-9. doi: 10.1002/jso.23501. Epub 2013 Nov 19.

High levels of Hdmx promote cell growth in a subset of uveal melanomas.

Am J Cancer Res. 2012;2(5):492-507. Epub 2012 Aug 20.

Quality of evidence about effectiveness of treatments for metastatic uveal melanoma.

Trans Am Ophthalmol Soc. 2008;106:128-35; discussion 135-7.